Free Trial

Gateway Investment Advisers LLC Acquires 1,212 Shares of McKesson Co. (NYSE:MCK)

McKesson logo with Medical background

Gateway Investment Advisers LLC lifted its holdings in McKesson Co. (NYSE:MCK - Free Report) by 25.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 5,941 shares of the company's stock after purchasing an additional 1,212 shares during the quarter. Gateway Investment Advisers LLC's holdings in McKesson were worth $3,386,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Old North State Trust LLC lifted its stake in shares of McKesson by 1.6% in the third quarter. Old North State Trust LLC now owns 1,138 shares of the company's stock worth $563,000 after acquiring an additional 18 shares during the period. Black Diamond Financial LLC lifted its position in shares of McKesson by 1.3% in the 3rd quarter. Black Diamond Financial LLC now owns 1,525 shares of the company's stock worth $754,000 after purchasing an additional 19 shares during the period. QV Investors Inc. boosted its stake in shares of McKesson by 0.6% in the 3rd quarter. QV Investors Inc. now owns 3,499 shares of the company's stock valued at $1,730,000 after purchasing an additional 20 shares during the last quarter. ASB Consultores LLC increased its position in shares of McKesson by 2.4% during the third quarter. ASB Consultores LLC now owns 879 shares of the company's stock worth $435,000 after buying an additional 21 shares during the period. Finally, Old Port Advisors lifted its holdings in McKesson by 1.3% in the third quarter. Old Port Advisors now owns 1,742 shares of the company's stock valued at $861,000 after buying an additional 22 shares during the period. 85.07% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, EVP Leann B. Smith sold 579 shares of the business's stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $572.79, for a total transaction of $331,645.41. Following the transaction, the executive vice president now directly owns 864 shares of the company's stock, valued at approximately $494,890.56. The trade was a 40.12 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.11% of the stock is currently owned by insiders.

Analyst Ratings Changes

MCK has been the subject of a number of recent analyst reports. Leerink Partners decreased their price target on McKesson from $665.00 to $630.00 and set an "outperform" rating for the company in a report on Monday, October 7th. Mizuho began coverage on McKesson in a report on Wednesday, December 4th. They issued a "neutral" rating and a $630.00 target price for the company. Bank of America cut their price target on McKesson from $680.00 to $650.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of McKesson from $623.00 to $579.00 and set a "buy" rating for the company in a research note on Wednesday, September 25th. Finally, StockNews.com raised shares of McKesson from a "hold" rating to a "buy" rating in a research note on Wednesday, November 6th. Two investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $646.14.

Read Our Latest Stock Analysis on McKesson

McKesson Stock Performance

MCK traded down $2.50 during midday trading on Friday, reaching $592.69. The company had a trading volume of 686,346 shares, compared to its average volume of 622,630. McKesson Co. has a 12-month low of $464.42 and a 12-month high of $637.51. The business has a 50-day moving average price of $595.11 and a two-hundred day moving average price of $561.34. The stock has a market cap of $75.24 billion, a PE ratio of 30.69, a P/E/G ratio of 1.26 and a beta of 0.52.

McKesson (NYSE:MCK - Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The company reported $7.07 earnings per share for the quarter, beating analysts' consensus estimates of $6.88 by $0.19. The business had revenue of $93.65 billion during the quarter, compared to analyst estimates of $89.33 billion. McKesson had a net margin of 0.77% and a negative return on equity of 207.50%. McKesson's revenue was up 21.3% compared to the same quarter last year. During the same period in the previous year, the business earned $6.23 EPS. On average, research analysts anticipate that McKesson Co. will post 32.73 earnings per share for the current year.

McKesson Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, January 2nd. Investors of record on Monday, December 2nd were given a $0.71 dividend. The ex-dividend date of this dividend was Monday, December 2nd. This represents a $2.84 dividend on an annualized basis and a yield of 0.48%. McKesson's payout ratio is 14.71%.

McKesson Company Profile

(Free Report)

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

Further Reading

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Should You Invest $1,000 in McKesson Right Now?

Before you consider McKesson, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and McKesson wasn't on the list.

While McKesson currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines